Prognosis
FDA Will Force Vaccine-Safety Disclosures If Makers Don’t
Dr. Peter Marks, the director of the Center for Biologics Evaluation and Research at the FDA.
Photographer: Amanda Andrade-Rhoades for The Washington Post via Getty ImagesThis article is for subscribers only.
A top Food and Drug Administration official warned vaccine makers that the agency could call upon rarely-used powers to disclose significant safety issues, after being asked about month-old investigation into an experimental Covid-19 shot from by AstraZeneca Plc.
At an online event hosted by Johns Hopkins University and the University of Washington, FDA Center for Biologics Evaluation and Research Director Peter Marks said he “would encourage any manufacturers of a vaccine, any sponsor of a vaccine to be as transparent as possible.”